Intangible Assets and Goodwill

6 Months Ended

Jun. 30, 2013

Intangible Assets and Goodwill [Abstract]

Note 9 – Intangible Assets and Goodwill

Intangible assets consist of the following:

	June 30, 2013	December 31, 2012

Patents	$ 13,097	$ 13,097
Accumulated amortization	(11,262 )	(10,966 )

Patents, net of accumulated amortization	1,835	2,131


Customer-related intangibles	1,300	1,300
Accumulated amortization	(287 )	(213)

Customer-related intangibles, net of accumulated amortization	1,013	1,087

Total amortizing intangibles	$ 2,848	$ 3,218


Manufacturing segment goodwill	$ 21,521	$ 21,521
Services segment goodwill	607	607

Total goodwill	$ 22,128	$ 22,128

Patents are being amortized on a straight-line method over their remaining legal life from the date of acquisition. The weighted average remaining life of the Company's patents is 4 years. Amortization expense related to patents, which is included in cost of sales, was $148 for each of the three months ended June 30, 2013 and 2012, and $296 and $295 for the six months ended June 30, 2013 and 2012, respectively. Customer-related intangibles are being amortized from the date of acquisition and have a remaining life of 17 years. Amortization expense related to customer intangibles, which is included in selling, general and administrative expenses, was $37 for each of the three months ended June 30, 2013 and 2012 and $74 for each of the six months ended June 30, 2013 and 2012.

The estimated future intangible amortization at June 30, 2013 is as follows:

Six months ending December 31, 2013	$ 369
Year ending December 31, 2014	744
Year ending December 31, 2015	720
Year ending December 31, 2016	476
Year ending December 31, 2017	108
Thereafter	431

	$ 2,848

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details